AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
EX-VIVO HEPARIN LEVELS COMPARED WITH APTT RATIOS IN HEPARINIZED PATIENTS - RESULTS UTILIZING 10 DIFFERENT APTT REAGENTS
Authors: FABBRINI N MESSMORE HL BALBALE S PANZA L RUHLAND S CROSBY T EDWARDS B BIRD ML WEHRMACHER W BRACE L
Citation: N. Fabbrini et al., EX-VIVO HEPARIN LEVELS COMPARED WITH APTT RATIOS IN HEPARINIZED PATIENTS - RESULTS UTILIZING 10 DIFFERENT APTT REAGENTS, Thrombosis and haemostasis, 1997, pp. 1153-1153
FIBRINOGEN ASSAY IN PLASMA UTILIZING BOTHROPS ATROX VENOM
Authors: MESSMORE H SUNG G FARID S IQBAL O FABBRINI N
Citation: H. Messmore et al., FIBRINOGEN ASSAY IN PLASMA UTILIZING BOTHROPS ATROX VENOM, Thrombosis and haemostasis, 1997, pp. 1788-1788
SENSITIVITY OF 5 LATEX AGGLUTINATION-TEST KITS FOR D-DIMER AS COMPARED WITH AN ENZYME-IMMUNOASSAY TEST KIT
Authors: FABBRINI N RUHLAND S MESSMORE HL BIRD ML BALBALE S CROSBY T EDWARDS B WEHRMACHER W BRACE L
Citation: N. Fabbrini et al., SENSITIVITY OF 5 LATEX AGGLUTINATION-TEST KITS FOR D-DIMER AS COMPARED WITH AN ENZYME-IMMUNOASSAY TEST KIT, Thrombosis and haemostasis, 1997, pp. 1789-1789
VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS
Authors: WALENGA JM JESKE W LEWIS BE FABBRINI N YANG L SZATKOWSKI E FASANELLA A HAAS S MESSMORE HL PIFARRE R
Citation: Jm. Walenga et al., VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS, Thrombosis and haemostasis, 1997, pp. 1840-1840
PRE-EXISTENCE OF ANTI-PF4-HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA
Authors: LEITZ H WALENGA JM FABBRINI N LEWIS BE FASANELLA A MESSMORE HL PIFARRE R
Citation: H. Leitz et al., PRE-EXISTENCE OF ANTI-PF4-HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA, Thrombosis and haemostasis, 1997, pp. 2302-2302
THE EFFECTS OF TOCOTRIENOLS AND LOVASTATIN ON CHOLESTEROL AND OTHER MARKERS OF THROMBOTIC RISK
Authors: BRACE LD FABBRINI N KHAN DA QURESHI AA BRADLOW BA
Citation: Ld. Brace et al., THE EFFECTS OF TOCOTRIENOLS AND LOVASTATIN ON CHOLESTEROL AND OTHER MARKERS OF THROMBOTIC RISK, Thrombosis and haemostasis, 1997, pp. 2496-2496
FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE REVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS
Authors: HOPPENSTEADT D LEWIS BE FABBRINI N LEITZ H FASANELLA A MESSMORE HL SCHWARZ R WALENGA JM
Citation: D. Hoppensteadt et al., FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE REVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS, Thrombosis and haemostasis, 1997, pp. 2607-2607
FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE LEVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS
Authors: HOPPENSTEADT D FABBRINI N LEITZ H WALENGA JM SCHWARZ R FAREED J
Citation: D. Hoppensteadt et al., FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE LEVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS, Blood, 88(10), 1996, pp. 707-707
VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, AND FLOW CYTOMETRIC METHODS/
Authors: JESKE W WALENGA JM HOPPENSTEADT D FABBRINI N YANG L SWATKOWSKI E FAREED J
Citation: W. Jeske et al., VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, AND FLOW CYTOMETRIC METHODS/, Blood, 88(10), 1996, pp. 1256-1256
PRE-EXISTANCE OF ANTIPLATETLET FACTOR-4 HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARIN OR LOW-MOLECULAR-WEIGHT HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA
Authors: FAREED J FABBRINI N LEITZ H HOPPENSTEADT D
Citation: J. Fareed et al., PRE-EXISTANCE OF ANTIPLATETLET FACTOR-4 HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARIN OR LOW-MOLECULAR-WEIGHT HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA, Blood, 88(10), 1996, pp. 2057-2057
PERFORMANCE-CHARACTERISTICS OF THE MORE RESPONSIVE THROMBOPLASTIN REAGENTS
Authors: FABBRINI N HEMPHILL S GODWIN J MESSMORE H BALBALE S LAY M PANZA L CROSBY T DILLON R BRACE L
Citation: N. Fabbrini et al., PERFORMANCE-CHARACTERISTICS OF THE MORE RESPONSIVE THROMBOPLASTIN REAGENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1113-1113
COMPARISON OF THE PERFORMANCE-CHARACTERISTICS OF 14 COMMERCIAL PARTIAL THROMBOPLASTIN REAGENTS
Authors: FABBRINI N MESSMORE H BRACE L HEMPHILL S BALBALE S LAY M PANZA L CROSBY T DILLON R GODWIN J CHEIFEC G
Citation: N. Fabbrini et al., COMPARISON OF THE PERFORMANCE-CHARACTERISTICS OF 14 COMMERCIAL PARTIAL THROMBOPLASTIN REAGENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1238-1238
EFFECT OF FREEZE - THAWING ON HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN LEVELS IN PLATELET POOR PLASMA
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., EFFECT OF FREEZE - THAWING ON HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN LEVELS IN PLATELET POOR PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1242-1242
UNIQUE BROAD-SPECTRUM SERINE-PROTEASE INHIBITOR IN A PATIENT WITH MULTIPLE-MYELOMA AND A THROMBOTIC DISORDER
Authors: MESSMORE HL FABBRINI N FARID S MORGAN J MCLEAN K TUEN B BHOOPALAM N HOPPENSTEADT D
Citation: Hl. Messmore et al., UNIQUE BROAD-SPECTRUM SERINE-PROTEASE INHIBITOR IN A PATIENT WITH MULTIPLE-MYELOMA AND A THROMBOTIC DISORDER, Thrombosis and haemostasis, 73(6), 1995, pp. 1430-1430
PILOT-STUDY TO DETERMINE USE OF A TAS ANALYZER IN AN ANTICOAGULATION CLINIC SETTING
Authors: FABBRINI N MESSMORE H BALBALE S PANZA L EDWARDS B FLYNN C JOVE M COURNOYER C ACUNCIUS L BIRD ML CROSBY T BRACE L
Citation: N. Fabbrini et al., PILOT-STUDY TO DETERMINE USE OF A TAS ANALYZER IN AN ANTICOAGULATION CLINIC SETTING, Blood, 86(10), 1995, pp. 3463-3463
THE ANTICOAGULANT EFFECT OF HEPARIN IS ALTERED BY A PENTASACCHARIDE
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., THE ANTICOAGULANT EFFECT OF HEPARIN IS ALTERED BY A PENTASACCHARIDE, Blood, 86(10), 1995, pp. 3514-3514
EFFECT OF FACTOR-VIII LEVELS ON THE CALCIUM THROMBIN TIME (CATT) OF HEPARINIZED NORMAL PLASMA
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., EFFECT OF FACTOR-VIII LEVELS ON THE CALCIUM THROMBIN TIME (CATT) OF HEPARINIZED NORMAL PLASMA, Blood, 86(10), 1995, pp. 3515-3515
WEEKLY AND YEARLY RHYTHMS IN PLASMA-FIBRINOGEN IN HOSPITALIZED MALE MILITARY VETERANS
Authors: KANABROCKI EL SOTHERN RB BREMNER WF DEMAKIS JG BEAN JT RINGELSTEIN JG RILEY C FABBRINI N CROSBY TJ MERMALL H THIRD JLHC SHIRAZI P OLWIN JH
Citation: El. Kanabrocki et al., WEEKLY AND YEARLY RHYTHMS IN PLASMA-FIBRINOGEN IN HOSPITALIZED MALE MILITARY VETERANS, The American journal of cardiology, 76(8), 1995, pp. 628
LUPUS ANTICOAGULANT ASSAYS
Authors: MESSMORE H FABBRINI N HOPPENSTEADT D LARACH F FAREED J
Citation: H. Messmore et al., LUPUS ANTICOAGULANT ASSAYS, Seminars in thrombosis and hemostasis, 20(1), 1994, pp. 79-88
PROTHROMBIN TIME - PERFORMANCE-CHARACTERISTICS OF THE MORE SENSITIVE THROMBOPLASTIN REAGENTS
Authors: FABBRINI N HEMPHILL S BALBALE S MESSMORE H BRACE L LAY M PANZA L CROSBY T DILLON R
Citation: N. Fabbrini et al., PROTHROMBIN TIME - PERFORMANCE-CHARACTERISTICS OF THE MORE SENSITIVE THROMBOPLASTIN REAGENTS, Blood, 84(10), 1994, pp. 10000200-10000200
UNIQUE CIRCULATING ANTICOAGULANT IN A MYELOMA PATIENT WITH PROTEIN-C DEFICIENCY AND VENOUS THROMBOSIS
Authors: MESSMORE H FABBRINI N FARID S MORGAN J MCLEAN K YUEN B FAREED J BHOOPALAM N HOPPENSTEADT D
Citation: H. Messmore et al., UNIQUE CIRCULATING ANTICOAGULANT IN A MYELOMA PATIENT WITH PROTEIN-C DEFICIENCY AND VENOUS THROMBOSIS, Blood, 84(10), 1994, pp. 10000680-10000680
VALIDATION OF HEPTEST AND A MODIFIED (HEPTEST-HI) IN MONITORING THERAPEUTIC ANTICOAGULATION BY HEPARINS
Authors: FABBRINI N KOZA M HOPPENSTEADT D WALENGA JM FASANELLA A MESSMORE H FAREED J
Citation: N. Fabbrini et al., VALIDATION OF HEPTEST AND A MODIFIED (HEPTEST-HI) IN MONITORING THERAPEUTIC ANTICOAGULATION BY HEPARINS, Thrombosis and haemostasis, 69(6), 1993, pp. 1109-1109
THE EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN ON THE WHOLE-BLOOD ACTIVATED CLOTTING TIME AS COMPARED WITH STANDARD HEPARIN
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., THE EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN ON THE WHOLE-BLOOD ACTIVATED CLOTTING TIME AS COMPARED WITH STANDARD HEPARIN, Thrombosis and haemostasis, 69(6), 1993, pp. 1111-1111
HEPTEST(TM) AND HEPTEST HI(TM) ARE UNINFLUENCED BY FACTOR-VIII LEVELSWHEN USED TO MONITOR HEPARIN-THERAPY
Authors: FABBRINI N FARID S KOZA M MESSMORE HL
Citation: N. Fabbrini et al., HEPTEST(TM) AND HEPTEST HI(TM) ARE UNINFLUENCED BY FACTOR-VIII LEVELSWHEN USED TO MONITOR HEPARIN-THERAPY, Thrombosis and haemostasis, 69(6), 1993, pp. 1119-1119
COMPARISON OF THE HEPTEST(R), HEPTEST HI(R) WITH THE ACTIVATED PARTIAL THROMBOPLASTIN TIME TO MONITOR LOW-MOLECULAR-WEIGHT HEPARIN-THERAPY
Authors: MESSMORE H FARID S FABBRINI N
Citation: H. Messmore et al., COMPARISON OF THE HEPTEST(R), HEPTEST HI(R) WITH THE ACTIVATED PARTIAL THROMBOPLASTIN TIME TO MONITOR LOW-MOLECULAR-WEIGHT HEPARIN-THERAPY, Blood, 82(10), 1993, pp. 10000597-10000597
Risultati: 1-25 | 26-26